| Market Cap | $48.04B+17.4% |
| Revenue (ttm) | $7.37B |
| Net Income | $1.44B |
| EPS | $5.07 |
| Shares Out | 281.97M |
| PE Ratio | 33.61 |
| Forward PE | 25.36 |
| Dividend | $1.05(0.62%) |
| Ex-Dividend Date | Jan 5, 2027 |
| Volume | 1,882,232 |
| Open | $175.10 |
| Previous Close | $175.34 |
| Day's Range | $169.40 - $175.12 |
| 52-Week Range | $108.35 - $182.99 |
| Beta | 1.24 |
| Analysts | Buy |
| Price Target | $183.14(+7.49%) |
| Earnings Date | Nov 23, 2026 |
About A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
12 firms rating A in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Nov 23, 2026Earnings report
- Jan 5, 2027Ex-dividend date
$A stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of A by members of U.S. Congress
| Ro KhannaHouse / D | Purchase$1.00K – $15.00K | Oct 13, 2026 |
| Julie JohnsonHouse / D | Purchase$1.00K – $15.00K | Sep 23, 2025 |
| Julie JohnsonHouse / D | Sale$1.00K – $15.00K | Sep 23, 2025 |
| Lisa C. McClainHouse / R | Sale$1.00K – $15.00K | Jul 16, 2025 |
| Lisa C. McClainHouse / R | Purchase$1.00K – $15.00K | Jun 17, 2025 |
| Julie JohnsonHouse / D | Sale$1.00K – $15.00K | Apr 1, 2025 |
| Julie JohnsonHouse / D | Sale$1.00K – $15.00K | Mar 3, 2025 |
| Sheldon WhitehouseSenate / D | Sale$1.00K – $15.00K | Feb 24, 2015 |
Recently reported changes in A holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by A's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
A Estimated quarterly lobbying spending
Source: U.S. Senate LDA
A Revenue by Segment or Geography
| Pharmaceutical and Biotechnology Market | $707.00M | 37.65% |
| Chemicals and Advanced Materials Market | $430.00M | 22.90% |
| Diagnostics and Clinical Market | $284.00M | 15.12% |
| Environmental and Forensics Market | $171.00M | 9.11% |
| Food Market | $158.00M | 8.41% |
| Academia and Government Market | $128.00M | 6.82% |
As of: Q3 2026 (Jul 31, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New A patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to A from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from A’s recent data — informational, not investment advice
What’s Behind the Score
News check: Agilent shows positive momentum with strong Q3 results on reshoring demand, dividend announcement, expected earnings growth, and new cancer panel launch.
Recent Insider Activity
Insider Score Trend Over Time
+0.0 since Sep 10Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| BEEZ | Honeytree U.S. Equity ETF | 4.82% |
| HHL.TO | Harvest Healthcare Leaders Income ETF | 4.65% |
| HIG.TO | Brompton Global Healthcare Income & Growth ETF | 4.40% |
| HIG-U.TO | Brompton Global Healthcare Income & Growth ETF | 4.40% |
| FIW | First Trust Water ETF | 4.30% |
| PHO | Invesco Water Resources ETF | 4.25% |
| AHOY | Newday Ocean Health ETF | 4.15% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 4.00% |
| EDOC | Global X Telemedicine & Digital Health ETF | 3.69% |
| PIO | Invesco Global Water ETF | 3.57% |
| KAT | Scharf ETF | 3.25% |
| APXH | Two Roads Shared Trust - APEX HealthCare ETF | 3.02% |
Weight is the stock’s share of each fund’s holdings.
